Uterine fibroid treatment device companies specialize in developing medical devices for the minimally invasive treatment of uterine fibroids. These companies contribute to gynecology and women's health by offering devices such as radiofrequency ablation tools and ultrasound-based devices that target and shrink uterine fibroids.
Boston Scientific Corporation received FDA approval for their transcervical embolization system, Sonata Eliteâ„¢, offering improved control and precision during uterine fibroid embolization (UFE).Partnered with healthcare providers to launch educational programs on fibroid treatment options and the benefits of UFE.
Hologic introduced their Acessaâ„¢ system, a minimally invasive ultrasound-guided ablation device for treating symptomatic uterine fibroids.Focused on expanding availability of Acessaâ„¢ through partnerships with hospitals and clinics worldwide.
Bayer AG continued promoting their Embozon® Embolic Microspheres, widely used for UFE procedures, highlighting their safety and efficacy.Collaborated with research institutions on developing new embolic materials for potentially improved UFE outcomes.
AngioDynamics launched their VisiCath® EZ Guide Catheter, designed to ease access during UFE procedures and improve procedural efficiency.Expanded their portfolio of embolic devices for UFE, catering to different fibroid sizes and locations.
Myovant Sciences and Pfizer received FDA approval for their MYFEMBREEâ„¢, a gonadotropin-releasing hormone (GnRH) antagonist for managing moderate to severe pain associated with uterine fibroids.Offering an alternative non-surgical treatment option for fibroid pain management.
List of Uterine Fibroid Treatment Device Key Companies in the Market
Uterine Fibroid Treatment Device Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)